WIREDGOV

Niall Dickson, co-chair of the Brexit Health Alliance, responding to the MHRA consultation on EU exit no-deal proposals

“We have to prepare for ‘no deal’, but no deal is not ideal.

“These proposals could reduce patients’ access to the medicines they need and may well mean delays in getting new medicines.

“With more new medicines emerging, this would be bad news for UK patients. We know that countries outside the European Medicines Agency can experience delays. Switzerland, despite a bilateral trade agreement with the EU, experiences delays in accessing new medicines.

“We have to find a way of exiting the EU without disrupting access to innovative and safe medicines both for patients in the UK and in Europe.”

MHRA consultation on EU exit no-deal legislative proposals